<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-R6AJZXR5</identifier><date>2013</date><creator>Zakotnik, Branko</creator><relation>documents/doc/R/URN_NBN_SI_doc-R6AJZXR5_001.pdf</relation><relation>documents/doc/R/URN_NBN_SI_doc-R6AJZXR5_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 17-25</format><identifier identifier_type="COBISSID_HOST">1665147</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-R6AJZXR5</identifier><language>slv</language><publisher>Zveza slovenskih društev za boj proti raku</publisher><source>Vloga genetike pri nastanku, zdravljenju in preprečevanju raka</source><rights>InC</rights><subject language_type_id="slv">biološka zdravila</subject><subject language_type_id="slv">monoklonska protitelesa</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">zaviralci receptorskih tirozinskih kinaz</subject><title>Biološka zdravila v onkologiji</title></Record>